韓國(guó)國(guó)際生物制藥峰會(huì)2012是南韓唯一探討生物制藥,疫苗和生物仿制藥產(chǎn)業(yè)和發(fā)展的獨(dú)特平臺(tái)。將于四月16-19日在首爾舉行。此次會(huì)議將聚集韓國(guó)與國(guó)際頂尖生物制藥企業(yè)的專家與學(xué)者,會(huì)著重于探討如何促進(jìn)生物制藥產(chǎn)品和疫苗的開發(fā)與生產(chǎn)。今日韓國(guó)的生物和生物仿造藥市場(chǎng)是亞洲發(fā)展最快和最有創(chuàng)新能力的市場(chǎng)之一,參會(huì)公司包括韓國(guó)三星,LG,綠十字等等制藥集團(tuán)和小型生物藥物研發(fā)公司。不要錯(cuò)過這個(gè)難得的機(jī)會(huì)來(lái)和韓國(guó)的藥企面對(duì)面,以及建立雙邊業(yè)務(wù)合作關(guān)系!
同期將會(huì)同時(shí)進(jìn)行生物藥研發(fā)和生產(chǎn)技術(shù)展會(huì)。2012年展臺(tái)機(jī)會(huì)有限,通用電器等國(guó)際集團(tuán)已經(jīng)確認(rèn)參展。如果您的公司需要打入韓國(guó)生物制藥市場(chǎng),現(xiàn)在就報(bào)名吧!
Speakers include:
B G Rhee, President, Green Cross, Korea
Tim Oldham, President, Asia Pacific, Hospira, Australia
Choi Chang Hoon, CEO, ISU Abxis, Korea
Yoo Jin San, President and CEO, PharmAbcine, Korea
Park Heung Rok, Director, ISU Abxis, China
Biologics World Korea 2012 brings you:
• The most targeted platform to meet Korean and international biologics manufacturers
• Case studies and discussions from senior level decision makers who will influence the direction of Korea's biologics industry
• Both strategic and technology-focused biologics development in Korea
Biologics World Korea 2012 Key topics include:
• Opportunities and challenges facing Korea Biologics Industry
• Innovation highlights: Biobetters and novel biologics development in Korea
• Innovation highlights: Vaccine Development in Korea
• Biomanufacturing upstream best practices
• Biomanufacturing downstream best practices
• Operational excellence and PAT
• Crystalballing the future of Korean industry